Table 2.
The association between SHMT2 and clinicopathologic factors.
Variables | SHMT2 | P* | |
---|---|---|---|
Low | High | ||
Sex | |||
Female | 21 | 28 | 0.587 |
Male | 40 | 41 | |
Age | |||
<60 | 22 | 22 | 0.711 |
≥60 | 39 | 47 | |
Tumor size | |||
≤5 cm | 29 | 22 | 0.068 |
>5 cm | 32 | 47 | |
Histopathological grade | |||
I | 20 | 13 | 0.068 |
II+III | 41 | 56 | |
T stage | |||
T1+T2 | 10 | 9 | 0.626 |
T3+T4 | 51 | 60 | |
Lymphatic invasion | |||
Negative | 20 | 12 | 0.042 |
Positive | 41 | 57 | |
Distant metastasis | |||
Negative | 56 | 64 | 0.839 |
Positive | 5 | 5 | |
TNM stage | |||
I–II | 29 | 18 | 0.149 |
III–IV | 32 | 51 |
SHMT2 is the abbreviation of serine hydroxymethyltransferase 2.
Calculated by the χ2 test.